{"id":"W2078797757","doi":"10.1016/j.ejca.2008.10.022","title":"A phase I and pharmacokinetic study of daily oral cediranib, an inhibitor of vascular endothelial growth factor tyrosine kinases, in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer: A study of the National Cancer Institute of Canada Clinical Trials Group","year":2008,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University of Ottawa; Queen's University; Ottawa Hospital","funders":"AstraZeneca","keywords":"Gemcitabine; Medicine; Pharmacokinetics; Cisplatin; Internal medicine; Nausea; Tolerability; Pharmacology; Phases of clinical research; Oncology; Chemotherapy; Gastroenterology; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002115562,0.00216781,0.005013773,0.0008617706,0.0008738251,0.001906799,0.001531371,0.002069628,0.00239709],"category_scores_gemma":[0.002259813,0.001464787,0.002302296,0.001056341,0.002180959,0.001490597,0.0004122731,0.005638951,0.0007994202],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002585601,"about_ca_system_score_gemma":0.003152244,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005871692,"about_ca_topic_score_gemma":0.01005038,"domain_scores_codex":[0.9991567,0.0003648846,0.00002959425,0.0001702854,0.00009840817,0.0001801817],"domain_scores_gemma":[0.9980224,0.0003190091,0.0003014284,0.0002212616,0.0001113565,0.001024524],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8193648,0.07588159,0.005752843,0.000465879,0.002400233,0.0002165824,0.0003920383,0.004406668,0.03212675,0.0004313515,0.004138936,0.05442235],"study_design_scores_gemma":[0.7277232,0.2525099,0.0122501,0.00002002653,0.0007155412,0.0002378651,0.00007648782,0.001679463,0.002390612,0.0002550749,0.002078222,0.00006358983],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929203,0.002048087,0.000619516,0.0004775845,0.0001447437,0.00122785,0.00123027,0.00008944915,0.00124212],"genre_scores_gemma":[0.9897457,0.00218896,0.001845155,0.0007061631,0.0001740623,0.001206015,0.002123659,0.00007057787,0.001939722],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005871692,"threshold_uncertainty_score":0.01875997,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.032184655486618,"score_gpt":0.354291009153011,"score_spread":0.3221063536663931,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}